⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LIXT News
Lixte Biotechnology Holdings, Inc. Common Stock
LIXTE Steps Into a Key Role in the Rise of Treatment Amplifiers
accessnewswire.com
LIXT
LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment
globenewswire.com
LIXT
LIXTE's Bold Blueprint to Rewire Cancer's Master Switch and Redefine Its Own Future (NASDAQ: LIXT)
accessnewswire.com
LIXT
LIXTE Bio's Transformational Summer Marked by Leadership Updates, Scientific Progress, and Digital Treasury Strategy (NASDAQ:LIXT)
accessnewswire.com
LIXT